Strata Skin Sciences Inc (OTCPK:SSKN)

Q3 2025 Strata Skin Sciences Inc Earnings Call Transcript

Nov 13, 2025 / 09:30 PM GMT

Release Date Price: $1.52 (-9.52%)

Transcript 10-Q8-K

Key Points

Positve

Strata Skin Sciences Inc (SSKN) is set to benefit from the historic expansion of CPT codes for its XT 308 nanometer excimer laser, which will expand reimbursement eligibility to multiple skin conditions starting January 1, 2027.
The Elevate 360 consulting model has shown success, with 99 clinics participating and experiencing an average growth of 7% year over year.
Average gross billings per device increased by 8.5% in Q3 2025, marking the highest since Q4 2022.
The company has achieved regulatory approval and initial commercial placement of TheraClearX in Mexico, indicating potential for international growth.
Strata Skin Sciences Inc (SSKN) has successfully engaged multiple dermatology clinics that were previously misled by competitors, resulting in over $1 million in annual capital and recurring revenue.

Negative

Total revenue for Q3 2025 was $6.9 million, down 20% compared to Q3 2024, primarily due to challenges in the international business environment.
Equipment revenue decreased by 60% in Q3 2025 compared to the prior year period.
The company continues to face challenges from the current trade policy of the United States government, impacting international revenue.
Net loss for Q3 2025 was $1.6 million, although this was an improvement from a net loss of $2.1 million in Q3 2024.
The ongoing litigation against Laser Optic is still unresolved, although the company is optimistic about potential outcomes.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SSKN.OQ - STRATA Skin Sciences Inc
Q3 2025 Strata Skin Sciences Inc Earnings Call
Nov 13, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the Strata Skin Sciences Inc. 3rd quarter, 2025 financial results and corporate update conference call. All participants will be in a listen-only mode. After today's presentation, there'll be an opportunity to ask questions. Please note today's event is being recorded. I would now like to turn the call over to Jules Abraham, Corps of IR.

The company's investor relations firm. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Arielle, and good afternoon,

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.